EUCTR2005-001959-38-DK进行中（未招募）1 期
Fase II trial with gemcitabine and oxaliplatin in patients with unknown primary tumours - UPT - unfit
Gedske Daugaard0 个研究点目标入组 39 人开始时间: 2005年6月16日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Unknown primary tumour
- •Performance 2 or age 66 to 75
- •Measurable lesion by RECIST
- •Expected life time more than 12 weeks
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Performance 0 or 1 and age below 66
- •another known cancer disease
研究者
相似试验
已完成
2 期
Phase II study of gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced biliary tract cancer (JASPAC02)gemcitabine refractory advanced biliary tract cancerJPRN-UMIN000003650Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)40
终止
2 期
A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast CancerBreast CancerNCT00674206Emory University6
已完成
2 期
Clinical Studies of Gemcitabine-OxaliplatinCentral Nervous System TumorsOsteosarcomaMedulloblastomaNeuroblastomaNCT00407433Gustave Roussy, Cancer Campus, Grand Paris156
已完成
2 期
Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsNon Small Cell Lung CancerNCT00271271Sanofi40
已完成
2 期
Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib TreatmentHepatocellular Carcinoma, Unresectable, AdvancedNCT05517239Yonsei University32